Search Results

There are 16713 results for: content related to: Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes

  1. The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease

    Journal of Surgical Oncology

    Volume 104, Issue 5, 1 October 2011, Pages: 458–465, Shuko Harada, Rosemarie Mick, Robert E. Roses, Holly Graves, Huilin Niu, Anupama Sharma, Jeanne E. Schueller, Harvey Nisenbaum, Brian J. Czerniecki and Paul J. Zhang

    Version of Record online : 9 MAY 2011, DOI: 10.1002/jso.21973

  2. You have full text access to this Open Access content
    HER2-Positive Endometrial Cancer Subtype Carries Poor Prognosis

    Clinical and Translational Science

    Volume 7, Issue 6, December 2014, Pages: 482–488, Sylwia Łapińska-Szumczyk, Anna Supernat, Hanna Majewska, Jacek Gulczyński, Agata Łuczak, Wojciech Biernat, Dariusz Wydra and Anna J. Żaczek

    Version of Record online : 9 SEP 2014, DOI: 10.1111/cts.12207

  3. Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women

    The Breast Journal

    Volume 19, Issue 1, January/February 2013, Pages: 22–30, N. Lynn Ferguson, John Bell, Robert Heidel, Solomon Lee, Stuart VanMeter, Lisa Duncan, Barbara Munsey, Timothy Panella and Amila Orucevic

    Version of Record online : 13 DEC 2012, DOI: 10.1111/tbj.12059

  4. You have full text access to this OnlineOpen article
    Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1122–1135, Huiyan Ma, Xinxin Xu, Giske Ursin, Michael S. Simon, Polly A. Marchbanks, Kathleen E. Malone, Yani Lu, Jill A. McDonald, Suzanne G. Folger, Linda K. Weiss, Jane Sullivan-Halley, Dennis M. Deapen, Michael F. Press and Leslie Bernstein

    Version of Record online : 27 APR 2015, DOI: 10.1002/cam4.465

  5. Is the TNM Staging System for Breast Cancer Still Relevant in the Era of Biomarkers and Emerging Personalized Medicine for Breast Cancer – An Institution's 10-year Experience

    The Breast Journal

    Volume 21, Issue 2, March/April 2015, Pages: 147–154, Amila Orucevic, Jason Chen, James M. McLoughlin, Robert E. Heidel, Timothy Panella and John Bell

    Version of Record online : 20 JAN 2015, DOI: 10.1111/tbj.12367

  6. You have free access to this content
    Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer


    Volume 118, Issue 20, 15 October 2012, Pages: 4936–4943, Michelle M. Kim, Shaheenah Dawood, Pamela Allen, Aysegul A. Sahin, Wendy A. Woodward, Benjamin D. Smith, Eric A. Strom, Kelly K. Hunt, Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo and Thomas A. Buchholz

    Version of Record online : 17 APR 2012, DOI: 10.1002/cncr.27502

  7. Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004

    The Breast Journal

    Volume 15, Issue 6, November/December 2009, Pages: 593–602, Carol A. Parise, Katrina R. Bauer, Monica M. Brown and Vincent Caggiano

    Version of Record online : 17 SEP 2009, DOI: 10.1111/j.1524-4741.2009.00822.x

  8. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma—a pilot study

    Diagnostic Cytopathology

    Issam M. Francis, Preeta Alath, Sara S. George, Mohammed Jaragh, Ayesha Al Jassar and Kusum Kapila

    Version of Record online : 26 SEP 2016, DOI: 10.1002/dc.23607

  9. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma


    Volume 23, Issue 3, June 2012, Pages: 181–186, K. Kumar S, N. Gupta, A. Rajwanshi, K. Joshi and G. Singh

    Version of Record online : 6 MAR 2011, DOI: 10.1111/j.1365-2303.2011.00853.x

  10. XXVII International Congress of the International Academy of Pathology October 12-17, 2008, Athens, Greece POSTER PRESENTATIONS


    Volume 53, Issue s1, October 2008, Pages: 1–432,

    Version of Record online : 24 SEP 2008, DOI: 10.1111/j.1365-2559.2008.03116.x

  11. You have free access to this content
    Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2869–2877, C.R. Beena Devi, Tieng Swee Tang and Marilys Corbex

    Version of Record online : 29 MAR 2012, DOI: 10.1002/ijc.27527

  12. You have free access to this content
    Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters


    Volume 112, Issue 5, March 2008, Pages: 995–1000, Sandip Basu, Wengen Chen, Julia Tchou, Ayse Mavi, Tevfik Cermik, Brian Czerniecki, Mitchell Schnall and Abass Alavi

    Version of Record online : 20 DEC 2007, DOI: 10.1002/cncr.23226

  13. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: A Comparison Study With Formalin-Fixed Cell Blocks and Surgical Biopsies

    Diagnostic Cytopathology

    Volume 41, Issue 7, July 2013, Pages: 575–581, Jill Ferguson, Pierce Chamberlain, Harvey M. Cramer and Howard H. Wu

    Version of Record online : 16 JUL 2012, DOI: 10.1002/dc.22897

  14. You have free access to this content
    Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: A case–case study

    International Journal of Cancer

    Volume 135, Issue 3, 01 August 2014, Pages: 669–681, Nan Song, Ji-Yeob Choi, Hyuna Sung, Seokang Chung, Minkyo Song, Sue K. Park, Wonshik Han, Jong Won Lee, Mi Kyung Kim, Keun-Young Yoo, Sei-Hyun Ahn, Dong-Young Noh and Daehee Kang

    Version of Record online : 10 JAN 2014, DOI: 10.1002/ijc.28685

  15. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas


    Volume 55, Issue 3, September 2009, Pages: 346–352, Raquel C M Fernandes, Jose L B Bevilacqua, Ibere C Soares, Sheila A C Siqueira, Luis Pires, Roberto Hegg and Filomena M Carvalho

    Version of Record online : 28 AUG 2009, DOI: 10.1111/j.1365-2559.2009.03380.x

  16. You have full text access to this Open Access content
    Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan

    Cancer Science

    Volume 101, Issue 5, May 2010, Pages: 1234–1240, Takakazu Kawase, Keitaro Matsuo, Takeshi Suzuki, Kaoru Hirose, Satoyo Hosono, Miki Watanabe, Masaki Inagaki, Hiroji Iwata, Hideo Tanaka and Kazuo Tajima

    Version of Record online : 15 JAN 2010, DOI: 10.1111/j.1349-7006.2010.01496.x

  17. Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer

    Journal of Cellular Biochemistry

    Volume 111, Issue 4, 1 November 2010, Pages: 782–790, Rebecca A. Burrell, Nicolai Juul, Stephen R. Johnston, Jorge S. Reis-Filho, Zoltan Szallasi and Charles Swanton

    Version of Record online : 27 JUL 2010, DOI: 10.1002/jcb.22781

  18. You have free access to this content
    Breast Pathology


    Volume 61, Issue s1, October 2012, Pages: 10–34,

    Version of Record online : 30 AUG 2012, DOI: 10.1111/j.1365-2559.2012.04359_2.x

  19. You have free access to this content
    The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases


    Volume 117, Issue 8, 15 April 2011, Pages: 1602–1611, Carey K. Anders, Allison M. Deal, C. Ryan Miller, Carmen Khorram, Hong Meng, Emily Burrows, Chad Livasy, Karen Fritchie, Matthew G. Ewend, Charles M. Perou and Lisa A. Carey

    Version of Record online : 29 NOV 2010, DOI: 10.1002/cncr.25746

  20. You have free access to this content
    Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo

    International Journal of Cancer

    Volume 126, Issue 12, 15 June 2010, Pages: 2893–2903, Michael A. Morse, Junping Wei, Zachary Hartman, Wenle Xia, Xiu-Rong Ren, Gangjun Lei, William T. Barry, Takuya Osada, Amy C. Hobeika, Sharon Peplinski, Haixiang Jiang, Gayathri R. Devi, Wei Chen, Neil Spector, Andrea Amalfitano, H. Kim Lyerly and Timothy M. Clay

    Version of Record online : 23 OCT 2009, DOI: 10.1002/ijc.24995